Abivax (ABVX) Other financing activities (2024 - 2026)

Abivax's Other financing activities history runs 3 years deep, the most recent figure standing at $9366.0 for Q1 2026.

• On a quarterly basis, Other financing activities fell 96.44% year-over-year to $9366.0 in Q1 2026; TTM through Mar 2026 was $65963.9, a 87.4% decrease from a year earlier, with the FY2025 full-year figure at $349213.1, up 31.69% from the prior year.
• Other financing activities declined to $9366.0 in Q1 2026 per ABVX's latest filing, from $56598.0 in the prior quarter.
• Across five years, Other financing activities topped out at $262971.1 in Q1 2025 and bottomed at $1098.2 in Q3 2024.
• The 3-year median for Other financing activities is $32982.0 (2025), against an average of $98803.7.
• Across the five-year window, Other financing activities surged 7968.86% in 2025 and tumbled 96.44% in 2026, its largest moves.
• Year by year, Other financing activities stood at $1098.2 in 2024, then jumped by 5053.61% to $56598.0 in 2025, then plunged by 83.45% to $9366.0 in 2026.
• Per Business Quant, the three latest ABVX Other financing activities figures stand at $9366.0 (Q1 2026), $56598.0 (Q2 2025), and $262971.1 (Q1 2025).